Brain interleukin-1 mediates chronic stress-induced depression in mice via adrenocortical activation and hippocampal neurogenesis suppression
The DOI matches its Crossref record; 84 of the 84 references it cites were found in a registry or an index.
Abstract
Several lines of evidence implicate the pro-inflammatory cytokine interleukin-1 (IL-1) in the etiology and pathophysiology of major depression. To explore the role of IL-1 in chronic stress-induced depression and some of its underlying biological mechanisms, we used the chronic mild stress (CMS) model of depression. Mice subjected to CMS for 5 weeks exhibited depressive-like symptoms, including decreased sucrose preference, reduced social exploration and adrenocortical activation, concomitantly with increased IL-1 beta levels in the hippocampus. In contrast, mice with deletion of the IL-1 receptor type I (IL-1rKO) or mice with transgenic, brain-restricted overexpression of IL-1 receptor antagonist did not display CMS-induced behavioral or neuroendocrine changes. Similarly, whereas in wild-type (WT) mice CMS significantly reduced hippocampal neurogenesis, measured by incorporation of bromodeoxyuridine (BrdU) and by doublecortin immunohistochemistry, no such decrease was observed IL-1rKO mice. The blunting of the adrenocortical activation in IL-1rKO mice may play a causal role in their resistance to depression, because removal of endogenous glucocorticoids by adrenalectomy also abolished the depressive-like effects of CMS, whereas chronic administration of corticosterone for 4 weeks produced depressive symptoms and reduced neurogenesis in both WT and IL-1rKO mice. The effects of CMS on both behavioral depression and neurogenesis could be mimicked by exogenous subcutaneous admin…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“There is growing evidence suggesting that positive ELS/CT history is an independent risk factor for peripheral immune dysregulation and long-term, low-grade inflammatory excess (i.e., a pro-inflammatory phenotype) in adulthood (101, 164–172).”
From Developmental Trajectories of Early Life Stress and Trauma: A Narrative Review on Neurobiological Aspects Beyond Stress System Dysregulation (2019) · cites this paper as [167]
Experimental — accuracy not yet measuredIn the citing paper
“Interestingly, animal findings suggest that pro-inflammatory cytokines also mediate chronic, stress-induced impairments in hippocampal neurogenesis (167)”
From Developmental Trajectories of Early Life Stress and Trauma: A Narrative Review on Neurobiological Aspects Beyond Stress System Dysregulation (2019) · cites this paper as [167]
In the citing paper
“A number of animal studies also support the association of inflammatory states with depressive symptoms, decreased hippocampal volumes, and “sickness behavior” (Goshen et al., 2008;Goshen and Yirmiya, 2009;Lawson et al., 2013).”
From A Review of the Relationship between Proinflammatory Cytokines and Major Depressive Disorder (2014) · cites this paper as Goshen et al., 2008
In the citing paper
“the removal of endogenous glucocorticoids abolished the depressive-like effects of CMS, indicating that the blunting of the adrenocortical activation may play a role in their resistance to develop depression”
From Glucocorticoids, cytokines and brain abnormalities in depression (2011) · cites this paper as Goshen et al., 2008
In the citing paper
“chronic administration of corticosterone produced depressive symptoms both in wild type and knockout mice, and the effects of CMS on behavioural depression could be mimicked by exogenous administration of IL-1beta”
From Glucocorticoids, cytokines and brain abnormalities in depression (2011) · cites this paper as Goshen et al., 2008
3 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene
Caspi, A., Sugden, K., Moffitt, T. E., Taylor, A., Craig, I. W., Harrington, H., McClay, J., Mill, J., Martin, J., Braithwaite, A., et al. (2003) · Science · doi:10.1126/science.1083968 · Cited by 8,120
Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants
Santarelli, L., Saxe, M., Gross, C., Surget, A., Battaglia, F., Dulawa, S., Weisstaub, N., Lee, J., Duman, R., Arancio, O., et al. (2003) · Science · doi:10.1126/science.1083328 · Cited by 4,321
Nestler, E. J., Barrot, M., DiLeone, R. J., Eisch, A. J., Gold, S. J., & Monteggia, L. M. (2002) · Neuron · doi:10.1016/s0896-6273(02)00653-0 · Cited by 3,217
Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus
Malberg, J. E., Eisch, A. J., Nestler, E. J., & Duman, R. S. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-24-09104.2000 · Cited by 3,111
Causal Relationship Between Stressful Life Events and the Onset of Major Depression
Kendler, K. S., Karkowski, L. M., & Prescott, C. A. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.6.837 · Cited by 2,566
Inflammatory Blockade Restores Adult Hippocampal Neurogenesis
Monje, M. L., Toda, H., & Palmer, T. D. (2003) · Science · doi:10.1126/science.1088417 · Cited by 2,426
THE EFFECTS OF STRESSFUL LIFE EVENTS ON DEPRESSION
Kessler, R. C. (1997) · Annual Review of Psychology · doi:10.1146/annurev.psych.48.1.191 · Cited by 2,111
Willner, P. (1997) · Psychopharmacology · doi:10.1007/s002130050456 · Cited by 1,832
Willner, P. (2005) · Neuropsychobiology · doi:10.1159/000087097 · Cited by 1,605
New approaches to antidepressant drug discovery: beyond monoamines
Berton, O., & Nestler, E. J. (2006) · Nature Reviews Neuroscience · doi:10.1038/nrn1846 · Cited by 1,589
Research works printed but not linked: 2
- Shapira-Lichter I, Beilin B, Bessler H, Ailon K, Ballas M, Shavit Y et al. Inflammatory cytokines and cholinergic signaling modulate stress-induced alterations in mood and cognition. Neural Plast 2004; 12: 55–56.
- Duman RS . Depression: a case of neuronal life and death? Biol Psychiatry 2004; 56: 140–145. · DOI · Paper page
Cited by
Items 101–200 of 777
Depression, dementia and immune dysregulation
Hayley, S., Hakim, A. M., & Albert, P. R. (2021) · Brain · doi:10.1093/brain/awaa405 · Cited by 186
Vinall, J., Pavlova, M., Asmundson, G., Rasic, N., & Noel, M. (2016) · Children · doi:10.3390/children3040040 · Cited by 183
The NLRP3 inflammasome in depression: Potential mechanisms and therapies
Xia, C.-Y., Guo, Y.-X., Lian, W.-W., Yan, Y., Ma, B.-Z., Cheng, Y.-C., Xu, J.-K., He, J., & Zhang, W.-K. (2023) · Pharmacological Research · doi:10.1016/j.phrs.2022.106625 · Cited by 178
Rizzo, L. B., Costa, L. G., Mansur, R. B., Swardfager, W., Belangero, S. I., Grassi-Oliveira, R., McIntyre, R. S., Bauer, M. E., & Brietzke, E. (2014) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2014.02.004 · Cited by 183
Adult Neurogenesis and Mental Illness
Schoenfeld, T. J., & Cameron, H. A. (2015) · Neuropsychopharmacology · doi:10.1038/npp.2014.230 · Cited by 182
“…induces behavioral phenotypes of depression, anxiety, and schizophrenia (Fahey et al, 2007; Takao et al, 2013; Wohleb et al, 2011), and suppresses proliferation and survival of new neurons in the dentate gyrus (Ekdahl et al, 2003; Goshen et al, 2007; Monje et al, 2003; Vallières et al, 2002).”
BackgroundThe Role of Inflammatory Cytokines in Cognition and Other Non-Motor Symptoms of Parkinson’s Disease
Menza, M., DeFronzo Dobkin, R., Marin, H., Mark, M. H., Gara, M., Bienfait, K., Dicke, A., & Kusnekov, A. (2010) · Psychosomatics · doi:10.1016/s0033-3182(10)70739-8 · Cited by 180
Psychiatric comorbidity in illicit drug users: Substance-induced versus independent disorders
Torrens, M., Gilchrist, G., & Domingo-Salvany, A. (2011) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2010.07.013 · Cited by 186
“Similar findings have been found in general population samples with Grant et al. (2004) reporting that while 11.08% of the general population had an independent anxiety disorder, less than one percent had a substance-induced anxiety disorder.”
ResultInfluentialReader, B. F., Jarrett, B. L., McKim, D. B., Wohleb, E. S., Godbout, J. P., & Sheridan, J. F. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.01.001 · Cited by 179
Cheng, Y., Pardo, M., Armini, R. D. S., Martinez, A., Mouhsine, H., Zagury, J.-F., Jope, R. S., & Beurel, E. (2016) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2015.12.012 · Cited by 174
“Rodents exhibiting depression-like behaviors also have elevated brain cytokine levels (Goshen et al., 2008; Kreisel et al., 2014), and administration of inflammatory cytokines causes depression-like behaviors in rodents (Bluthé et al., 2000; De La Garza, 2005; Dantzer and Kelley, 2007; Palin et…”
Li, R., Wang, X., Qin, T., Qu, R., & Ma, S. (2016) · Behavioural Brain Research · doi:10.1016/j.bbr.2015.09.031 · Cited by 169
Haase, J., & Brown, E. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.10.002 · Cited by 175
Rodent Models of Depression: Neurotrophic and Neuroinflammatory Biomarkers
Stepanichev, M., Dygalo, N. N., Grigoryan, G., Shishkina, G. T., & Gulyaeva, N. (2014) · BioMed Research International · doi:10.1155/2014/932757 · Cited by 169
“[89] showed that mice subjected to CMS for 5 weeks exhibited depressive-like symptoms, including decreased sucrose preference, reduced social exploration and adrenocortical activation, and increased IL-1β level in the hippocampus.”
BackgroundCassano, P., Petrie, S. R., Hamblin, M. R., Henderson, T. A., & Iosifescu, D. V. (2016) · Neurophotonics · doi:10.1117/1.nph.3.3.031404 · Cited by 170
“Indeed, animal research has shown that IL-1 mediates chronic depression in mice by suppressing hippocampal neurogenesis.(44) One proinflammatory cytokine that may be of particular relevance to depression is CSF IL-6 (IL6 measured in cerebrospinal fluid).”
BackgroundGlucocorticoids Orchestrate Divergent Effects on Mood through Adult Neurogenesis
Lehmann, M. L., Brachman, R. A., Martinowich, K., Schloesser, R. J., & Herkenham, M. (2013) · The Journal of Neuroscience · doi:10.1523/jneurosci.3878-12.2013 · Cited by 168
“, 2007) or adrenalectomy (Goshen et al., 2008) to block behavioral and neural alterations induced by chronic stressors.”
BackgroundResultAn Animal Model of a Behavioral Intervention for Depression
Pollak, D. D., Monje, F. J., Zuckerman, L., Denny, C. A., Drew, M. R., & Kandel, E. R. (2008) · Neuron · doi:10.1016/j.neuron.2008.07.041 · Cited by 166
“Immobility was even further decreased in the presence of the safety signal in fluoxetine-treated safety-trained mice (Figure 3B).”
BackgroundMethodInflammation Models of Depression in Rodents: Relevance to Psychotropic Drug Discovery
Remus, J. L., & Dantzer, R. (2016) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyw028 · Cited by 164
“Rodent models of depression are also associated with elevated levels of inflammation in the periphery and brain (Grippo et al., 2005; Goshen et al., 2008; You et al., 2011).”
BackgroundLu, Y., Ho, C. S., Liu, X., Chua, A. N., Wang, W., McIntyre, R. S., & Ho, R. C. (2017) · PLOS ONE · doi:10.1371/journal.pone.0186700 · Cited by 164
Gárate, I., García-Bueno, B., Madrigal, J. L., Bravo, L., Berrocoso, E., Caso, J. R., Micó, J. A., & Leza, J. C. (2011) · Journal of Neuroinflammation · doi:10.1186/1742-2094-8-151 · Cited by 165
“This can be considered particularly significant, bearing in mind that this cytokine plays a central role in the sickness behavior detected in animals after LPS injection (LPS induces its release) and has been proposed as a possible actor involved in the pathophysiology of depression [6,44].”
BackgroundLi, M.-X., Zheng, H.-L., Luo, Y., He, J.-G., Wang, W., Han, J., Zhang, L., Wang, X., Ni, L., Zhou, H.-Y., et al. (2018) · Molecular Psychiatry · doi:10.1038/mp.2017.76 · Cited by 163
Neuropsychiatric Comorbidity in Obesity: Role of Inflammatory Processes
Castanon, N., Lasselin, J., & Capuron, L. (2014) · Frontiers in Endocrinology · doi:10.3389/fendo.2014.00074 · Cited by 161
“Alterations in these mechanisms have been fully documented in models of chronic stress exposure, a well-admitted contributor of mood disorders (134, 135).”
BackgroundAltered neuro-inflammatory gene expression in hippocampus in major depressive disorder
Mahajan, G. J., Vallender, E. J., Garrett, M. R., Challagundla, L., Overholser, J. C., Jurjus, G., Dieter, L., Syed, M., Romero, D. G., Benghuzzi, H., et al. (2018) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2017.11.017 · Cited by 159
Microglia in neuronal plasticity: Influence of stress
Delpech, J.-C., Madore, C., Nadjar, A., Joffre, C., Wohleb, E. S., & Layé, S. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.12.034 · Cited by 171
“Moreover, several studies using chronic unpredictable or mild stress indicate that perturbed neuroimmune function is linked to depressive-like behavior (Goshen et al., 2008; Koo and Duman, 2008; Koo et al., 2010).”
BackgroundMaes, M. H. J., Mihaylova, I., Kubera, M., Uytterhoeven, M., Vrydags, N., & Bosmans, E. (2009) · PubMed · Cited by 176
Maes, M., Song, C., & Yirmiya, R. (2012) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2012.718331 · Cited by 159
“In one study, mice with genetically impaired IL-1 signaling (IL-1R-KO or IL-1RA transgenic mice) were found to display no depressive-like symptoms, including reduced social exploration and sucrose preference, following exposure to chronic unpredictable stress (CUS) [78].”
BackgroundInfluentialSelf-citationTherapeutic Strategies for Treatment of Inflammation-related Depression
Adzic, M., Brkic, Z., Mitic, M., Francija, E., Jovicic, M. J., Radulovic, J., & Maric, N. P. (2018) · Current Neuropharmacology · doi:10.2174/1570159x15666170828163048 · Cited by 156
“BDNF fosters neurogenesis, an important prerequisite for an AD response, and has been shown to be reduced by IL-1β and TNF-α and their downstream signalling pathways, including NF-κB in stressinduced animal models of depression [108, 109].”
BackgroundEffects of neuroinflammation on the regenerative capacity of brain stem cells
Russo, I., Barlati, S., & Bosetti, F. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.07168.x · Cited by 156
Therapeutic Implications of Brain–Immune Interactions: Treatment in Translation
Miller, A. H., Haroon, E., & Felger, J. C. (2017) · Neuropsychopharmacology · doi:10.1038/npp.2016.167 · Cited by 152
Yin, Y., Ju, T., Zeng, D., Duan, F., Zhu, Y., Liu, J., Li, Y., & Lu, W. (2024) · Pharmacological Research · doi:10.1016/j.phrs.2024.107322 · Cited by 178
Guadagno, J., Swan, P., Shaikh, R., & Cregan, S. P. (2015) · Cell Death & Disease · doi:10.1038/cddis.2015.151 · Cited by 149
“Both embryonic and adult NPCs express IL-1R1 and it has been demonstrated that recombinant IL-1β can decrease the proliferation of NPCs in culture,(20,21) and that hippocampal neurogenesis is impaired in mice chronically exposed to IL-1β in vivo.(22,23) Elevated levels of IL-1β and impaired hippocampal neurogenesis ha…”
BackgroundInfluentialWager-Smith, K., & Markou, A. (2011) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2010.09.010 · Cited by 151
“…al. 2006, Chen H. et al. 2006, Cherng et al. 2010, Czeh et al. 2001, Czeh et al. 2002, Czeh et al. 2007, Dagyte et al. 2009, Ferragud et al. 2010, Goshen et al. 2008, Gould et al. 1997, Heine et al. 2004, Hill et al. 2006, Koo and Duman 2008, Lagace et al. 2010, Lee K.J. et al. 2006, Luo et al.…”
BackgroundMethodInfluentialRole of neuro-immunological factors in the pathophysiology of mood disorders
Bhattacharya, A., Derecki, N. C., Lovenberg, T. W., & Drevets, W. C. (2016) · Psychopharmacology · doi:10.1007/s00213-016-4214-0 · Cited by 149
Stress induced microglial activation contributes to depression
Li, B., Yang, W., Ge, T., Wang, Y., & Cui, R. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2022.106145 · Cited by 151
Matsuda, T., Murao, N., Katano, Y., Juliandi, B., Kohyama, J., Akira, S., Kawai, T., & Nakashima, K. (2015) · Nature Communications · doi:10.1038/ncomms7514 · Cited by 145
Novel Aspects of Glucocorticoid Actions
Uchoa, E. T., Aguilera, G., Herman, J. P., Fiedler, J. L., Deak, T., & de Sousa, M. B. C. (2014) · Journal of Neuroendocrinology · doi:10.1111/jne.12157 · Cited by 148
Maes, M. H. J., Mihaylova, I., Kubera, M., Uytterhoeven, M., Vrydags, N., & Bosmans, E. (2010) · Journal of Affective Disorders · doi:10.1016/j.jad.2009.12.014 · Cited by 154
Nrf2 participates in depressive disorders through an anti-inflammatory mechanism
Martín-de-Saavedra, M. D., Budni, J., Cunha, M. P., Gómez-Rangel, V., Lorrio, S., del Barrio, L., Lastres-Becker, I., Parada, E., Tordera, R. M., Rodrigues, A. L. S., et al. (2013) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2013.03.020 · Cited by 143
“, 2004) and decrease neuroplasticity (Barrientos et al., 2004; Ben Menachem-Zidon et al., 2008; Goshen et al., 2008; Koo and Duman, 2008).”
Alcoholism and inflammation: Neuroimmunology of behavioral and mood disorders
Kelley, K. W., & Dantzer, R. (2011) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2010.12.013 · Cited by 141
Liu, W., Sheng, H., Xu, Y., Liu, Y., Lu, J., & Ni, X. (2013) · Behavioural Brain Research · doi:10.1016/j.bbr.2012.12.041 · Cited by 170
Menachem-Zidon, O. B., Goshen, I., Kreisel, T., Menahem, Y. B., Reinhartz, E., Hur, T. B., & Yirmiya, R. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301606 · Cited by 162
“We have recently demonstrated that chronic mild stress, as well as chronic administration of IL-1b, markedly reduces hippocampal neurogenesis (Goshen et al, 2007).”
BackgroundSelf-citationRole of the intestinal microbiome, intestinal barrier and psychobiotics in depression
Trzeciak, P., & Herbet, M. (2021) · Nutrients · doi:10.3390/nu13030927 · Cited by 139
“Research conducted in rodents indicates that administration of IL-1 causes depressive disorders, including withdrawal from social behavior and decreased sexual activity [32].”
BackgroundChronic unpredictable stress promotes neuronal apoptosis in the cerebral cortex
Bachis, A., Cruz, M. I., Nosheny, R. L., & Mocchetti, I. (2008) · Neuroscience Letters · doi:10.1016/j.neulet.2008.06.081 · Cited by 138
“These data support a previous suggestion that CMS induces an alteration in the dynamics of HPA axis [14].”
BackgroundResultNeuroendocrine Regulation of Brain Cytokines After Psychological Stress
Johnson, J. D., Barnard, D. F., Kulp, A. C., & Mehta, D. M. (2019) · Journal of the Endocrine Society · doi:10.1210/js.2019-00053 · Cited by 135
Salehpour, F., Farajdokht, F., Cassano, P., Sadigh‐Eteghad, S., Erfani, M., Hamblin, M. R., Salimi, M. M., Karimi, P., Rasta, S. H., & Mahmoudi, J. (2018) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2018.10.010 · Cited by 153
Early prenatal exposure to LPS results in anxiety- and depression-related behaviors in adulthood
Depino, A. M. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.04.065 · Cited by 132
Lehmann, M. L., Mustafa, T., Eiden, A. M., Herkenham, M., & Eiden, L. E. (2013) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2012.09.006 · Cited by 134
“…CORT administration is sufficient to induce depressive-like changes in behavior (Zhao et al., 2008, 2009), whereas the glucocorticoid receptor antagonist mifepristone (RU-486) (Wu et al., 2007) or adrenalectomy (Goshen et al., 2008) block behavioral alterations induced by chronic mild stressors.”
BackgroundMinocycline: Therapeutic Potential in Psychiatry
Dean, O. M., Data-Franco, J., Giorlando, F., & Berk, M. (2012) · CNS Drugs · doi:10.2165/11632000-000000000-00000 · Cited by 131
“Impeding neurogenesis in models of depression leads to treatment resistance.([35]) Neurogenesis thus appears to be a critical pathway to depression, and in treatment response.”
BackgroundMaes, M., & Twisk, F. N. (2010) · BMC Medicine · doi:10.1186/1741-7015-8-35 · Cited by 131
“Carlo-Stella N, Badulli C, De Silvestri A, Bazzichi L, Martinetti M, Lorusso L, Bombardieri S, Salvaneschi L, Cuccia M: A first study of cytokine genomic polymorphisms in CFS: positive association of TNF-857 and IFNgamma 874 rare alleles.”
Inflammation‐driven brain and gut barrier dysfunction in stress and mood disorders
Doney, E., Cadoret, A., Dion‐Albert, L., Lebel, M., & Ménard, C. (2021) · European Journal of Neuroscience · doi:10.1111/ejn.15239 · Cited by 150
HPA Axis Interactions with Behavioral Systems
Packard, A. E. B., Egan, A. E., & Ulrich‐Lai, Y. M. (2016) · Comprehensive physiology · doi:10.1002/cphy.c150042 · Cited by 149
Wu, M. D., Hein, A. M., Moravan, M. J., Shaftel, S. S., Olschowka, J. A., & O’Banion, M. K. (2012) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2011.09.012 · Cited by 129
“More recent evidence suggests that adult neurogenesis may be involved in other behaviors such as stress (Ben Menachem-Zidon et al., 2008; Goshen et al., 2008; Koo and Duman, 2008; Lagace et al., 2010) and depressive-like behavior (David et al.”
BackgroundResultInfluentialEvidence for IL-1 receptor blockade as a therapeutic strategy for the treatment of depression.
Koo, J. W., & Duman, R. S. (2009) · PubMed · Cited by 155
Menachem-Zidon, O. B., Avital, A., Menahem, Y. B., Goshen, I., Kreisel, T., Shmueli, E., Segal, M., Hur, T. B., & Yirmiya, R. (2010) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2010.11.007 · Cited by 149
Self-citationRescue of IL-1β-induced reduction of human neurogenesis by omega-3 fatty acids and antidepressants
Borsini, A., Alboni, S., Horowitz, M. A., Tojo, L. M., Cannazza, G., Su, K.-P., Pariante, C. M., & Zunszain, P. A. (2017) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2017.05.006 · Cited by 126
Prieto, G. A., Snigdha, S., Baglietto-Vargas, D., Smith, E. D., Berchtold, N. C., Tong, L., Ajami, D., LaFerla, F. M., Rebek, J., & Cotman, C. W. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1514486112 · Cited by 126
“It stands to reason that the increased IL-1R1–AcP receptor sensitivity at the synapse is likely a common mechanism increasing neuronal vulnerability in brain diseases associated with IL-1β–driven neuroinflammation, such as depression (63), chronic stress (64), and AD (65).”
BackgroundLiu, Y.-N., Peng, Y.-L., -Liu, L., Wu, T.-Y., Zhang, Y., Lian, Y.-J., Yang, Y.-Y., Kelley, K. W., Jiang, C.-L., & Wang, Y.-X. (2015) · European Cytokine Network · doi:10.1684/ecn.2015.0362 · Cited by 126
“In another study, it was reported that UCMS caused depression-like behavior, similar tothose found in the present study [14].”
Piirainen, S., Youssef, A. M., Song, C., Kalueff, A. V., Landreth, G. E., Malm, T., & Tian, L. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2017.01.046 · Cited by 136
Zhang, W.-Y., Guo, Y.-J., Han, W.-X., Yang, M.-Q., Wen, L.-P., Wang, K.-Y., & Jiang, P. (2019) · International Immunopharmacology · doi:10.1016/j.intimp.2018.12.012 · Cited by 123
Neuroinflammation as an etiological trigger for depression comorbid with inflammatory bowel disease
Craig, C. F., Filippone, R. T., Stavely, R., Bornstein, J. C., Apostolopoulos, V., & Nurgali, K. (2022) · Journal of Neuroinflammation · doi:10.1186/s12974-021-02354-1 · Cited by 124
“Furthermore, mice with chronic stress-induced depression display increased IL‐1β expression in the dorsal hippocampus that decreases dentate gyrus hippocampal neurogenesis [217].”
BackgroundCouch, Y., Trofimov, A., Markova, N., Nikolenko, V., Steinbusch, H. W., Chekhonin, V., Schroeter, C., Lesch, K.-P., Anthony, D. C., & Strekalova, T. (2016) · Journal of Neuroinflammation · doi:10.1186/s12974-016-0572-0 · Cited by 122
“sion of pro-inflammatory cytokines IL-1β and TNFα contribute to anhedonia and behavioural measures of helplessness after chronic stress [28, 29].”
BackgroundGreen, H. F., Treacy, E., Keohane, A., Sullivan, A. M., O’Keeffe, G. W., & Nolan, Y. M. (2012) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2012.01.001 · Cited by 131
“, 2001) and depression (Goshen et al., 2007).”
BackgroundInfluentialHoyo-Becerra, C., Schlaak, J., & Hermann, D. M. (2014) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2014.06.200 · Cited by 130
Potential roles of zinc in the pathophysiology and treatment of major depressive disorder
Swardfager, W., Herrmann, N., McIntyre, R. S., Mazereeuw, G., Goldberger, K., Cha, D. S., Schwartz, Y., & Lanctôt, K. L. (2013) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2013.03.018 · Cited by 116
Szczepanska‐Sadowska, E. K., Cudnoch‐Jędrzejewska, A., Ufnal, M., & Żera, T. (2010) · PubMed · Cited by 130
Reduced brain somatostatin in mood disorders: a common pathophysiological substrate and drug target?
Lin, L.-C., & Sibille, E. (2013) · Frontiers in Pharmacology · doi:10.3389/fphar.2013.00110 · Cited by 116
Zhang, B., Wang, P., Hu, K., Li, L., Yu, X. L., Lu, Y., & Hong-sheng, C. (2019) · Molecules · doi:10.3390/molecules24112035 · Cited by 120
Major Depression Is a Risk Factor for Low Bone Mineral Density: A Meta-Analysis
Yirmiya, R., & Bab, I. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.03.016 · Cited by 130
Self-citationSong, C., Liu, B.-P., Zhang, Y., Peng, Z., Wang, J., Collier, A. D., Echevarria, D. J., Savelieva, K. V., Lawrence, R. F., Rex, C. S., et al. (2017) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2017.08.021 · Cited by 124
“These cytokines were chosen based on their well-established role in stress and neuroinflammation (Goshen et al., 2008; Wong et al., 1997), also see (Wajant et al., 2003).”
InfluentialInterleukin-1β Causes Anxiety by Interacting with the Endocannabinoid System
Rossi, S., Sacchetti, L., Napolitano, F., De Chiara, V., Motta, C., Studer, V., Musella, A., Barbieri, F., Bari, M., Bernardi, G., et al. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.1515-12.2012 · Cited by 112
“Instead, studies involving genetic deletion of IL-1 receptor (Goshen et al., 2008) and those involving systemic (Norman et al., 2010) or central administration of IL-1ra (present study) using mice that were not exposed to stressful paradigms, found that these mice spent more time than control mice…”
Aschbacher, K., Epel, E., Wolkowitz, O. M., Prather, A. A., Puterman, E., & Dhabhar, F. S. (2012) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2011.10.010 · Cited by 112
“Animal models further underscore the central role of IL-1b in stress-induced depression (Goshen et al., 2008; Nguyen et al., 1998).”
Inflammation and the developing brain: Consequences for hippocampal neurogenesis and behavior
Green, H. F., & Nolan, Y. M. (2014) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2014.01.004 · Cited by 130
Alboni, S., Poggini, S., Garofalo, S., Milior, G., El Hajj, H., Lecours, C., Girard, I., Gagnon, S., Boisjoly-Villeneuve, S., Brunello, N., et al. (2016) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2016.07.155 · Cited by 111
“These results show that, in line with the literature (Cheng et al., 2016; Goshen et al., 2008; Singhal et al., 2014), the stressful condition increased immune activation compared to the enriched condition.”
Majidi, J., Kosari-Nasab, M., & Salari, A.-A. (2016) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2015.10.009 · Cited by 109
Does minocycline have antidepressant effect?
Pae, C., Marks, D. M., Han, C., & Patkar, A. A. (2008) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2007.12.005 · Cited by 117
“We postulate that minocycline may have the potential to directly attenuate or reverse neuronal atrophy in the context of major depression by upregulating hippocampal neurogenesis.”
BackgroundEvidence for Inflammation-Associated Depression
Liu, C. S., Adibfar, A., Herrmann, N., Gallagher, D., & Lanctôt, K. L. (2016) · Current topics in behavioral neurosciences · doi:10.1007/7854_2016_2 · Cited by 123
Song, M., Ruan, J., Zhang, R., Deng, J., Ma, Z., & Ma, S. (2018) · Acta Pharmacologica Sinica · doi:10.1038/aps.2017.208 · Cited by 110
The vascular niche in adult neurogenesis
Licht, T., & Keshet, E. (2015) · Mechanisms of Development · doi:10.1016/j.mod.2015.06.001 · Cited by 112
Self-citationWang, Y., Xu, Y., Sheng, H., Ni, X., & Lu, J. (2016) · Behavioural Brain Research · doi:10.1016/j.bbr.2016.03.044 · Cited by 116
Datson, N. A., van den Oever, J. M. E., Korobko, O. B., Magarinos, A. M., de Kloet, E. R., & McEwen, B. S. (2013) · Endocrinology · doi:10.1210/en.2012-2233 · Cited by 105
Picard, K., Bisht, K., Poggini, S., Garofalo, S., Golia, M. T., Basilico, B., Abdallah, F., Ciano Albanese, N., Amrein, I., Vernoux, N., et al. (2021) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2021.07.022 · Cited by 102
Serotonin of mast cell origin contributes to hippocampal function
Nautiyal, K. M., Dailey, C. A., Jahn, J. L., Rodriquez, E., Son, N. H., Sweedler, J. V., & Silver, R. (2012) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2012.08138.x · Cited by 95
“…instance of an immune system cell contribution to normal brain development and extend the existing body of work that shows that immune cells and their signaling molecules contribute to normal hippocampal function (Raison et al., 2006; Ziv et al., 2006; Goshen et al., 2008; Koo & Duman, 2008).”
Shinohara, R., Taniguchi, M., Ehrlich, A. T., Yokogawa, K., Deguchi, Y., Chérasse, Y., Lazarus, M., Urade, Y., Ogawa, A., Kitaoka, S., et al. (2017) · Molecular Psychiatry · doi:10.1038/mp.2017.177 · Cited by 110
Yang, H., Li, M., Zhou, M., Xu, H., Huan, F., Liu, N., Gao, R., Wang, J., Zhang, N., & Jiang, L. (2021) · Inflammation · doi:10.1007/s10753-021-01514-y · Cited by 107
Faster, better, stronger: Towards new antidepressant therapeutic strategies
O’Leary, O. F., Dinan, T. G., & Cryan, J. F. (2014) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2014.07.046 · Cited by 115
Datson, N. A., Speksnijder, N., Mayer, J. L., Steenbergen, P. J., Korobko, O., Goeman, J., de Kloet, E. R., Joëls, M., & Lucassen, P. J. (2012) · Hippocampus · doi:10.1002/hipo.20905 · Cited by 100
“depression (Dantzer et al., 2008; Goshen et al., 2008; Khairova et al., 2009; Lucassen et al., 2010a).”
BackgroundFatigue in Newly Diagnosed Inflammatory Bowel Disease
Grimstad, T., Norheim, K. B., Isaksen, K., Leitao, K., Hetta, A. K., Carlsen, A., Karlsen, L. N., Skoie, I. M., Gøransson, L., Harboe, E., et al. (2015) · Journal of Crohn's and Colitis · doi:10.1093/ecco-jcc/jjv091 · Cited by 99
Gáll, Z., Farkas, S., Albert, Á., Ferencz, E., Vancea, S., Urkon, M., & Kolcsár, M. (2020) · Biomolecules · doi:10.3390/biom10050801 · Cited by 101
“The majority of publications associate the applied physical and social stressors with a substantial decrease in sucrose solution intake [57,58].”
BackgroundSympathetic nervous system contributes to enhanced corticosterone levels following chronic stress
Lowrance, S. A., Ionadi, A., McKay, E., Douglas, X., & Johnson, J. D. (2016) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2016.02.027 · Cited by 110
“There is precedence for brain cytokines to contribute to sympathetic nervous system responses to acute stressors (Engler et al., 2008; Goshen et al., 2008; Goshen and Yirmiya, 2009) but Psychoneuroendocrinology.”
BackgroundInfluentialMüller, L., Benedetto, S. D., & Müller, V. (2025) · Cells · doi:10.3390/cells14010054 · Cited by 106
Interleukin-15 regulates proliferation and self-renewal of adult neural stem cells
Gómez-Nicola, D., Valle-Argos, B., Pallas-Bazarra, N., & Nieto-Sampedro, M. (2011) · Molecular Biology of the Cell · doi:10.1091/mbc.e11-01-0053 · Cited by 97
Serlin, Y., Levy, J., & Shalev, H. (2011) · Cardiovascular Psychiatry and Neurology · doi:10.1155/2011/609202 · Cited by 99
“Inflammation stimulates release or production of corticotropin releasing hormone (CRF), adrenocorticotropic hormone (ACTH) and cortisol via activation of the hypothalamic-pituitary-adrenal axis (HPA) and cortisol in turn may participate in neural atrophy [108, 109].”
BackgroundInterleukin-17 inhibits Adult Hippocampal Neurogenesis
Liu, Q., Xin, W., He, P., Turner, D., Yin, J., Gan, Y., Shi, F.-D., & Wu, J. (2014) · Scientific Reports · doi:10.1038/srep07554 · Cited by 95
Identification and treatment of symptoms associated with inflammation in medically ill patients
Dantzer, R., Capuron, L., Irwin, M. R., Miller, A. H., Ollat, H., Perry, V. H., Rousey, S., & Yirmiya, R. (2007) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2007.10.008 · Cited by 109
“In contrast, IL-1 receptor type 1 knockout (IL-1rKO) mice or mice with transgenic overexpression of brain IL-1ra did not exhibit any depressive-like effects of CMS (Goshen et al., 2007).”
InfluentialSelf-citationChabry, J., Nicolas, S., Cazareth, J., Murris, E., Guyon, A., Glaichenhaus, N., Heurteaux, C., & Petit-Paitel, A. (2015) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2015.07.018 · Cited by 104
“Inversely, both cytokines and lipopolysaccharide (LPS) can induce depressive-like behaviors in rodents after peripheral (Yirmiya, 1996; Swiergiel and Dunn, 2007; Goshen et al., 2008) and central administration (O’Connor et al., 2009; Kaster et al., 2012; Fu et al., 2010).”
BackgroundLearning, memory, and glial cell changes following recovery from chronic unpredictable stress
Bian, Y., Pan, Z., Hou, Z., Huang, C., Li, W., & Zhao, B. (2012) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2012.04.008 · Cited by 109
Inserra, A., Mastronardi, C. A., Rogers, G., Licinio, J., & Wong, M.-L. (2019) · Molecular Neurobiology · doi:10.1007/s12035-018-1359-3 · Cited by 96
Xu, Y., Sheng, H., Tang, Z., Lu, J., & Ni, X. (2015) · Behavioural Brain Research · doi:10.1016/j.bbr.2015.04.017 · Cited by 105
Maes, M. H. J. (2010) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.06.023 · Cited by 115
“Different animalmodels of depression, such as CMS and olfactory bulbectomized (OB) rat models show signs of peripheral and central (neuro)inflammation (Kubera et al. 1996, 2001; Song and Leonard, 1995, Goshen et al., 2008).”
Modulation of microglial activation by antidepressants
Mariani, N., Everson, J., Pariante, C. M., & Borsini, A. (2022) · Journal of Psychopharmacology · doi:10.1177/02698811211069110 · Cited by 89
“In fact, it is clear that dysfunctions in excitatory and/or inhibitory glutamate and gamma-aminobutyric acid (GABA) signalling mechanisms may play a critical role in depression (Fee et al., 2017; Goshen et al., 2008; Luscher and Fuchs, 2015; Luscher et al., 2011).”
BackgroundResultThe Role of Brain Interleukin-1 in Stress-Enhanced Fear Learning
Jones, M., Lebonville, C. L., Barrus, D. G., & Lysle, D. T. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2014.317 · Cited by 110
“There is evidence that IL-1b is upregulated throughout the brain after stress exposure (Nguyen et al, 1998; O'Connor et al, 2003) and is important in stress-induced hypothalamic– pituitary–adrenal axis regulatory responses (Goshen et al, 2008).”
Boulle, F., Massart, R., Stragier, E., Païzanis, E., Zaidan, L., Marday, S., Gabriel, C., Mocaer, E., Mongeau, R., & Lanfumey, L. (2014) · Translational Psychiatry · doi:10.1038/tp.2014.125 · Cited by 91
Metadata
- Authors
- Goshen, I., Kreisel, T., Ben-Menachem-Zidon, O., Licht, T., Weidenfeld, J., Ben-Hur, T., & Yirmiya, R.
- Affiliations
- Hebrew University of Jerusalem (IL)
- Hadassah Medical Center (IL)
- Corresponding author
- Yirmiya, R
- Venue
- Molecular Psychiatry
- Published
- 2007-08-14
- Volume
- 13
- Issue
- 7
- Pages
- 717-728
- ISSN
- 1359-4184 (ISSN-L)
- 1476-5578
- OpenAlex
- W2104205224
- Cited by
- 762
- References
- 84
- Citations by year
- 2026: 20 · 2025: 30 · 2024: 28 · 2023: 39 · 2022: 49 · 2021: 60 · 2020: 38 · 2019: 50 · 2018: 50 · 2017: 52 · 2016: 58 · 2015: 54 · 2014: 46 · 2013: 39 · 2012: 45
- FWCI
- 7.72
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Molecular Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Hebrew University of Jerusalem
- Israel Science Foundation
- Topics
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Life Sciences › Neuroscience › Developmental Neuroscience › Neurogenesis and neuroplasticity mechanisms
- Keywords
- IL-1β, chronic stress, depression, hippocampal neurogenesis, adrenocortical activation, IL-1 receptor type I, interleukin-1 receptor antagonist, glucocorticoids, corticosterone, adrenalectomy, inflammatory cytokines, antidepressant targets, sucrose preference, social exploration
- MeSH terms
- Adrenal Cortex, Animals, Brain, Bromodeoxyuridine, Chronic Disease, Depression, Enzyme-Linked Immunosorbent Assay, Hippocampus, Interleukin-1, Mice, Inbred C57BL, Mice, Transgenic, Stress, Psychological, Receptors, Interleukin-1, Mice, Knockout, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.